Tokyo, Dec. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060062) titled 'Prospective Observational Study of Patients Receiving Neuromodulation Services' on Dec. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Chronic Central Nervous System Related Motor Paralysis and Rare Neurological and Neuromuscular Diseases
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study will be conducted to evaluate the effects of neuromodulation training on physical function in individuals with chronic central nervous system related motor paralysis and rare neurological or neuromuscular diseases.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Chronic central motor paralysis, including stroke or spinal cord injury, and rare neurological or neuromuscular diseases
2.Patients who are able to provide verbal consent to participate in this study
As this observational study targets individuals who undergo neuromodulation based training, and eligibility for the training itself is determined by age, no additional age criteria are set for participants in this study.
Key exclusion criteria - 1.Individuals who have received any form of cell transplantation within the past year
2. Patients with progressive malignant tumors
3. Patients deemed unsuitable for participation by the principal investigator or coinvestigators
Target Size - 500
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2024 Year 12 Month 23 Day
Date of IRB - 2024 Year 12 Month 23 Day
Anticipated trial start date - 2025 Year 11 Month 01 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068688
Disclaimer: Curated by HT Syndication.
